Atrás
Rango del Día
$75.25
$116.19
Rango de 52 Semanas
$75.25
$116.19
Volumen
800
Promedio 50D / 200D
$116.19
/
$93.07
Cierre Anterior
$116.19
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 32.0 | 0.4 |
| P/B | — | 2.9 |
| ROE % | — | 3.8 |
| Net Margin % | 4.4 | 3.9 |
| Rev Growth 5Y % | 1.9 | 10.0 |
| D/E | — | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$5.31
$5.19 – $5.39
|
5.1 B | 1 |
| FY2029 |
$4.83
$4.71 – $4.89
|
4.9 B | 1 |
| FY2028 |
$4.52
$4.41 – $4.58
|
4.7 B | 1 |
Puntos Clave
Revenue grew 1.92% annually over 5 years — modest growth
Generating 272.48M in free cash flow
P/E of 31.95 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3.60%
Cash machine — converts 150.39% of earnings into free cash flow
Capital efficient — spends only 0.66% of revenue on capex
Crecimiento
Revenue Growth (5Y)
1.92%
Revenue (1Y)5.52%
Earnings (1Y)-0.96%
FCF Growth (3Y)35.08%
Calidad
Return on Equity
N/A
ROICN/A
Net Margin4.38%
Op. Margin5.39%
Seguridad
Debt / Equity
N/A
Current RatioN/A
Interest Coverage14.24
Valoración
P/E Ratio
31.95
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5.52% | Revenue Growth (3Y) | 5.10% |
| Earnings Growth (1Y) | -0.96% | Earnings Growth (3Y) | 2.16% |
| Revenue Growth (5Y) | 1.92% | Earnings Growth (5Y) | 1.96% |
| Profitability | |||
| Revenue (TTM) | 4.14B | Net Income (TTM) | 181.19M |
| ROE | N/A | ROA | N/A |
| Gross Margin | 10.37% | Operating Margin | 5.39% |
| Net Margin | 4.38% | Free Cash Flow (TTM) | 272.48M |
| ROIC | N/A | FCF Growth (3Y) | 35.08% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | N/A |
| Interest Coverage | 14.24 | Dividend Yield | 0.03% |
| Valuation | |||
| P/E Ratio | 31.95 | P/B Ratio | N/A |
| P/S Ratio | 1.40 | PEG Ratio | -23.26 |
| EV/EBITDA | N/A | Dividend Yield | 0.03% |
| Market Cap | 5.79B | Enterprise Value | N/A |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.14B | 3.92B | 3.75B | 4.01B | 3.83B |
| Net Income | 181.19M | 182.95M | 173.60M | 165.13M | 167.68M |
| EPS (Diluted) | 3.63 | 3.67 | 5.72 | 3.32 | 3.38 |
| Gross Profit | 429.01M | 1.09B | 451.33M | 374.13M | 350.55M |
| Operating Income | 222.88M | 204.35M | 191.29M | 192.98M | 186.33M |